efocipegtrutide (HM15211) - Hanmi
Efocipegtrutide: Data from P2b trial (NCT04505436) for MASH in 2025 (Hanmi) - Nov 7, 2024 - Q3 2024 Results: Completion of P2b trial for MASH in H2 2025 
P2b data • Trial completion date • Metabolic Dysfunction-Associated Steatohepatitis
https://www.hanmipharm.com/file/admin/ir/1727656306902.pdf
 
Nov 7, 2024
 
 
ef3dfbd8-8f19-4082-8cb0-05d6689b23c9.png

3c6659ec-fcd9-487f-a976-31fb374f74c3.png